Children’s Cancer Institute

Site

Children’s Cancer Institute

Accreditation No.

20992

Site No.

25230

Date of Accreditation

12 Apr 2024

Address

Lowy Cancer Research Centre
Unsw Sydney, NSW 2052
Australia

ccia.org.au

Contact

Availability

Services conditionally available to external clients

Supervision

S (Specialised)

Scope of Accreditation

Withdrawn 12 Apr 2024

Voluntary

Children’s Cancer Institute

ISO 15189 (2012)

Human Pathology

Withdrawn
Service Product Determinant
Haematology - Full blood examination Blood; Bone marrow Leucocyte count (white blood cell count, WBCC)
Molecular genetics - DNA extraction Blood; Bone marrow; Cerebrospinal fluid (CSF); Tissue biopsy; Trephine Viable DNA; Viable DNA for sequencing
Molecular genetics - DNA fragment size analysis Blood; Bone marrow; Cerebrospinal fluid (CSF); Tissue biopsy; Trephine DNA fragment size determination
Molecular genetics - Screening for an unknown mutation - Targeted genes Blood; Bone marrow; Cerebrospinal fluid (CSF); Tissue biopsy; Trephine Minimal residual disease (MRD)
Molecular genetics - Screening for an unknown mutation - Targeted panels for non-inherited (somatic) DNA/RNA changes Blood; Bone marrow; Cerebrospinal fluid (CSF); Tissue biopsy; Trephine Minimal residual disease (MRD)

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.